Why last year’s flu shot may not be enough this season

If you received a flu vaccine last year, you might wonder whether you really need another dose this season. The answer is yes for most people who are eligible for seasonal influenza vaccination—not because every new vaccine is entirely different, but because the viruses that cause flu continue to evolve and protection from previous vaccination can decline over time.

The distinction matters. A flu vaccine is reviewed and updated each season, but not every component must change, and you do not necessarily need to switch brands. The aim is to keep vaccine formulations aligned as closely as possible with the influenza viruses expected to circulate in the coming months.

The World Health Organization (WHO) coordinates global surveillance and consults experts twice a year to recommend the composition of seasonal influenza vaccines for the Northern and Southern hemispheres. National regulatory authorities then determine which vaccine formulations are approved and used in their countries.

For patients, the practical message is straightforward: last season’s vaccination may offer some residual protection, but it should not be assumed to provide adequate protection throughout the following season.

Why flu vaccines are reviewed every year

Influenza viruses change as they spread and replicate. Small genetic changes can alter the viral proteins that the immune system recognises, a process known as antigenic drift. As a result, the strains circulating in one season may differ from those that caused most infections in the previous year.

Scientists monitor these changes to help identify the influenza viruses most likely to circulate during the next season. Vaccine experts then assess surveillance findings, laboratory evidence and immune-response data before recommending which strains should be included in the updated formulation.

“Every year there are different strains of the flu that are predicted to be more virulent,” Amy Lynn Safaty Valentine, PharmD, MBA, a pharmacy district leader for CVS Pharmacy on Long Island, New York, told Health. “A new vaccine is developed each year. It’s important to make sure you get the most up-to-date vaccine each season.”

The important point is that vaccine composition is reviewed annually, not that every strain is necessarily replaced. Some components may remain similar between seasons, while others are changed to reflect the latest evidence.

The US Food and Drug Administration (FDA), working with public health experts, recommends the strains to be included in vaccines for the US season. The WHO provides recommendations for vaccine composition globally, while individual countries make decisions about the products used in their own populations.

What changed in the 2026–2027 flu vaccine?

The FDA recommended an updated three-strain formulation for the 2026–2027 influenza season in the United States. The vaccines are designed to target two influenza A viruses—H1N1 and H3N2—and one influenza B virus from the Victoria lineage.

The recommended strains differ according to the manufacturing method. For egg-based vaccines, the recommended components are an A/Missouri/11/2025-like H1N1 virus, an A/Darwin/1454/2025-like H3N2 virus and a B/Tokyo/EIS13-175/2025-like virus from the B/Victoria lineage. Cell-based and recombinant vaccines use a different recommended H3N2 strain and a different B/Victoria strain.

These are US seasonal recommendations, not a guarantee that every country will use identical products or formulations. Pakistan’s available vaccines and applicable guidance should be checked with a local healthcare professional or relevant health authority.

The update illustrates how the vaccine is adapted to changing influenza viruses. It does not mean that every vaccine brand is new or that patients must change manufacturers each year.

Why last year’s flu shot may not be enough

There are two main reasons annual vaccination remains important.

First, immune protection following vaccination declines over time. The degree of decline varies with factors including age, health status and the vaccine response an individual develops.

Second, the influenza viruses circulating in the next season may not be the same as those targeted by the previous season’s formulation. Even when a vaccine offers some continuing protection, a closer match between the vaccine and circulating viruses can improve its ability to prevent influenza illness.

This does not mean last year’s vaccine becomes completely ineffective overnight. Nor does it mean that everyone vaccinated previously will become infected. It means that previous vaccination should not be treated as a substitute for the recommended dose for the current season.

Annual vaccination is recommended in the United States for people aged six months and older, with limited exceptions. Individual recommendations and available products may differ elsewhere.

How dangerous is seasonal influenza?

Influenza is a contagious respiratory infection that can cause anything from a short-lived illness to severe complications requiring hospital treatment. It spreads mainly through respiratory particles released when infected people cough, sneeze or talk.

The WHO estimates that seasonal influenza causes around one billion cases worldwide each year, including three to five million cases of severe illness and approximately 290,000 to 650,000 respiratory deaths. These are global estimates, not figures for Pakistan alone.

Complications can include pneumonia, ear and sinus infections, and worsening of existing health conditions such as asthma, diabetes and heart disease. Older adults, young children, pregnant women and people with certain chronic medical conditions may be at greater risk of severe illness.

Babies younger than six months are too young to receive currently recommended seasonal flu vaccines in the United States. Vaccination of eligible household members and caregivers can therefore form part of a broader strategy to reduce the risk of exposure to vulnerable infants.

Vaccination does not eliminate every risk of infection, but it remains an important measure for reducing influenza illness and its potentially serious consequences.

When does protection begin, and how long does it last?

A flu vaccine does not provide immediate protection. The US Centers for Disease Control and Prevention (CDC) says the body takes about two weeks after vaccination to develop antibodies that help protect against influenza viruses represented in the vaccine. Someone exposed to the virus shortly after vaccination may become ill before this immune response develops.

Protection can then weaken over subsequent months, although the duration and strength of immunity vary between individuals. This is one reason experts recommend vaccination for each new season rather than relying on a dose received many months earlier.

Timing matters, too. Ideally, vaccination should occur early enough for the immune response to develop before influenza activity increases in the community. The best timing depends on local influenza patterns and public health guidance.

In the United States, September and October are commonly recommended vaccination months for many people ahead of the usual winter season. That timing should not automatically be applied to Pakistan, where local seasonal patterns, vaccine availability and public health advice need to be considered. People in Pakistan should ask a qualified doctor or pharmacist when to receive the currently recommended seasonal vaccine.

Which flu vaccines are available?

There is no single flu vaccine product suitable for everyone. Different formulations are designed for particular age groups or use different manufacturing technologies. The options below describe products licensed in the United States; their availability and approval status may differ in Pakistan.

Standard injectable vaccines

Several injectable vaccines are available for eligible age groups. They are designed to stimulate an immune response against the influenza strains included in the seasonal formulation.

The precise product recommended may depend on age, medical history, availability and local guidance. Receiving the same brand in successive years is not inherently a problem if the product remains appropriate and its current-season formulation is being used.

Higher-dose and adjuvanted vaccines for older adults

In the United States, the CDC preferentially recommends three influenza vaccines for people aged 65 and older: Fluzone High-Dose, Flublok and Fluad. These vaccines use different approaches to stimulate an immune response, and the recommendations are based on evidence suggesting potential advantages for older adults compared with standard-dose, unadjuvanted vaccines. <Cite refs={["turn626816search4","turn626816search12"]}/>

These products are not interchangeable with every other vaccine for every patient. Older adults should discuss the age-appropriate options with their healthcare provider, particularly if a preferred product is unavailable.

The nasal spray option

FluMist is a nasal spray vaccine containing weakened live influenza viruses. In the United States, it is approved for eligible people aged two through 49 years, but it is not suitable for everyone in that age range.

Pregnant people and individuals with certain medical conditions should not receive the nasal spray formulation. Its eligibility requirements differ from those for injectable vaccines, so a healthcare professional should assess whether it is appropriate.

A newer mRNA flu vaccine

In August 2026, the US FDA approved Moderna’s mFLUSIVA, an mRNA-based seasonal influenza vaccine for people aged 50 and older. The approval is traditional for adults aged 50–64 and accelerated for those aged 65 and older, based on immune-response measures that are expected to predict clinical benefit in the older group.

In a Phase 3 trial involving more than 40,000 adults aged 50 and older, the vaccine demonstrated 26.6% greater relative efficacy than a standard-dose influenza vaccine against the study’s defined influenza-like illness outcome. This is a relative efficacy measure from that trial; it should not be interpreted as a guarantee of protection for every individual or as proof that the vaccine is superior in every population or against every outcome.

The US approval does not establish that mFLUSIVA is approved or available in Pakistan. Patients should not assume that a newly approved product in another country can be obtained locally or is the best option for them.

Can the flu shot give you influenza?

No. Injectable flu vaccines do not cause influenza. Some people experience temporary side effects, including a sore arm, headache, muscle aches or fatigue, as the immune system responds to vaccination. These symptoms are not the same as having influenza.

The nasal spray vaccine contains weakened influenza viruses and has different eligibility considerations, but it is designed for eligible recipients and is not equivalent to catching seasonal flu.

Amelia MacIntyre, DO, a family medicine physician practising in San Diego, California, told Health that the belief that a flu shot causes influenza is a misconception. She explained that vaccination primes the body's immune system to recognise and fight the virus.

It is also possible to catch influenza after vaccination. This may happen if exposure occurs before immunity develops, if the person encounters a virus not adequately covered by the vaccine or if the immune response is incomplete. The vaccine can nevertheless reduce the risk of severe illness among people who become infected.

Vaccination also does not protect against every other virus that can cause flu-like symptoms, including some viruses responsible for common colds and other respiratory infections.

What if you have already had the flu?

Having influenza earlier in the season does not necessarily protect you against all the other strains that may circulate. A healthcare professional can advise whether and when vaccination is appropriate after recovery, taking account of your age, health and the vaccine available.

If you are currently ill, have had a severe reaction to a previous flu vaccine or have a condition that may affect vaccine choice, seek individual advice rather than assuming that every product is suitable.

The same principle applies to people who received a vaccine in a previous season: check the recommendation for the current season rather than relying on memory of the last dose.

Where should you get vaccinated?

Flu vaccines may be offered through hospitals, clinics, doctors’ offices and pharmacies, depending on the country and the products authorised locally. Use a qualified healthcare provider or licensed vaccination service that can confirm the vaccine’s approval status, formulation, storage and suitability for your age and medical history.

In the United States, pharmacies such as CVS offer flu vaccination services, and eligibility and insurance coverage can be checked through the provider. These arrangements are specific to the US healthcare system and should not be assumed to apply in Pakistan.

For readers in Pakistan, a local doctor or pharmacist can help identify the appropriate seasonal vaccine, explain any age- or health-related precautions and advise on timing.

The bottom line

A flu vaccine is reviewed every year because influenza viruses evolve and protection from earlier vaccination can decline. The formulation may be updated without every strain changing, and you may not need to switch brands—but you should not assume last year’s vaccination is sufficient for this season.

Vaccination is not a guarantee that you will never catch influenza. It remains an important way to reduce the risk of illness and potentially serious complications, particularly for people more vulnerable to severe disease.

If you are unsure which vaccine is available or appropriate for you, speak with a qualified healthcare professional and follow the seasonal guidance issued in your country.

Stay connected with Medical News Pakistan

CLICK HERE TO FOLLOW with Medical News Pakistan on WhatsApp for verified global medical breakthroughs, FDA approvals, healthcare innovations, clinical research updates and the latest developments affecting patients and healthcare professionals.